Volpara Health Technologiesの機関の所有権
Volpara Health Technologiesの機関の所有権は何ですか。
Volpara Health Technologies Limitedの機関の所有権は14.80%です。
機関の所有権の定義は何ですか。
機関所有権は、ミューチュアル・ファンドまたは年金基金、保険会社、投資会社、その他の資金を管理する他の団体が所有する会社の株式数です。
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
ASXのセクタHealth Careにおける機関の所有権の企業と比べるVolpara Health Technologies
Volpara Health Technologiesは何をしますか。
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry worldwide. The company offers Volpara Analytics software, a cloud-based breast imaging analytics platform that delivers performance monitoring solutions; Volpara Live, which provides radiographers instant patient-based image quality feedback; Volpara Lung, a patient management software; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses Tyrer-Cuzick v8 Risk Evaluation Tool to calculate patients' risk of developing breast cancer; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. Volpara Health Technologies Limited has a strategic relationship with RevealDx to enhance lung screening capabilities. The company was formerly known as Matakina Technology Ltd. and changed its name to Volpara Health Technologies Limited in October 2015. Volpara Health Technologies Limited was incorporated in 2009 and is headquartered in Wellington, New Zealand.
Volpara Health Technologiesと類似の機関の所有権
- Journeyの機関の所有権は14.77%です。
- UEXの機関の所有権は14.78%です。
- Carnarvon Petroleumの機関の所有権は14.78%です。
- Vgp Nvの機関の所有権は14.78%です。
- VGP NVの機関の所有権は14.78%です。
- Murray Cod Australiaの機関の所有権は14.79%です。
- Volpara Health Technologiesの機関の所有権は14.80%です。
- Value & Income Trust Plcの機関の所有権は14.80%です。
- Akwelの機関の所有権は14.80%です。
- Orgenesis Incの機関の所有権は14.80%です。
- Golar LNG Partners LPの機関の所有権は14.81%です。
- Colonial Coal Internationalの機関の所有権は14.82%です。
- IOUの機関の所有権は14.87%です。